- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Oncodesign Precision Medicine SA (ALOPM)
The Oncodesign Precision Medicine share price today is 0.32, view EPA ALOPM stock exchange data. Track the latest Oncodesign Precision Medicine share price with real-time updates on ALOPM stock performance including market cap, day range, 52-week range and dividend yield. Access ALOPM charts, earnings dates and analyst estimates to support your investment decisions.
0.32
-0.03(-8.57%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.32
0.35
52 wk Range
0.20
0.92
ALOPM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.320.35
52 wk Range
0.200.92
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALOPM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
22-09-2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare ALOPM to Peers and Sector
Metrics to compare | ALOPM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALOPMPeersSector | |
|---|---|---|---|---|
P/E Ratio | 1.1x | −2.2x | −0.3x | |
PEG Ratio | 0.01 | −0.03 | 0.00 | |
Price/Book | 1.0x | −0.4x | 2.6x | |
Price / LTM Sales | 3.4x | 4.5x | 2.9x | |
Upside (Analyst Target) | - | 289.4% | 64.3% | |
Fair Value Upside | Unlock | 7.1% | 10.0% | Unlock |
Oncodesign Precision Medicine Société anonyme, a biopharmaceutical company, engages in the precision medicine business. The company’s product pipeline consist of OPM-101, a RIPK2 inhibitor for the treatment of inflammatory bowel disease and immuno-oncology; OPM-102 to treat cancer; and OPM-201, a LRRK2 inhibitor for the treatment of Parkinson’s disease. It also focuses on the development of a radiotheranostic molecule portfolio for the diagnosis and the treatment of advanced digestive cancers under PROMETHE brand; Nanocyclix, a kinase inhibitors, as well as on developing treatment for pancreatic and other cancers. Oncodesign Precision Medicine Société anonyme was founded in 1995 and is based in Dijon, France.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Oncodesign Precision Medicine (ALOPM) Share Price Today?
The Oncodesign Precision Medicine share price today is 0.32.
What is the current Oncodesign Precision Medicine (ALOPM) share price and day range?
As of 15-10-2026, the Oncodesign Precision Medicine share price is 0.32, with a previous close of 0.32. The share price has ranged from 0.32 to 0.35 today, while the 52-week range spans from 0.20 to 0.92.
What Is the Oncodesign Precision Medicine Market Cap?
As of today, Oncodesign Precision Medicine market cap is 6.66M.
What Is Oncodesign Precision Medicine's Earnings Per Share (TTM)?
The Oncodesign Precision Medicine EPS (TTM) is 0.30.
When Is the Next Oncodesign Precision Medicine Earnings Date?
Oncodesign Precision Medicine will release its next earnings report on 02-12-2026.
From a Technical Analysis Perspective, Is ALOPM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Oncodesign Precision Medicine Trade On?
Oncodesign Precision Medicine is listed and trades on the Paris Stock Exchange.
What Is the Stock Symbol for Oncodesign Precision Medicine?
The stock symbol for Oncodesign Precision Medicine is "ALOPM."
How Many Times Has Oncodesign Precision Medicine Stock Split?
Oncodesign Precision Medicine has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.